Search by Drug Name or NDC

NDC 00078-0670-66 VOTRIENT 200 mg/1 Details

VOTRIENT 200 mg/1

VOTRIENT is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is PAZOPANIB HYDROCHLORIDE.

MedlinePlus Drug Summary

Pazopanib is used to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in the cells of the kidneys) in adults. Pazopanib is in a class of medications called kinase inhibitors. It works by slowing or stopping the spread of cancer cells.

Related Packages: 00078-0670-66
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Pazopanib

Product Information

NDC	00078-0670
Product ID	0078-0670_929749e3-ee9b-4550-b583-c78290919caf
Associated GPIs	21533042100320
GCN Sequence Number	065777
GCN Sequence Number Description	pazopanib HCl TABLET 200 MG ORAL
HIC3	V1Q
HIC3 Description	ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS
GCN	27829
HICL Sequence Number	036709
HICL Sequence Number Description	PAZOPANIB HCL
Brand/Generic	Brand
Proprietary Name	VOTRIENT
Proprietary Name Suffix	n/a
Non-Proprietary Name	pazopanib hydrochloride
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	200
Active Ingredient Units	mg/1
Substance Name	PAZOPANIB HYDROCHLORIDE
Labeler Name	Novartis Pharmaceuticals Corporation
Pharmaceutical Class	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA022465
Listing Certified Through	n/a

Package

NDC 00078-0670-66 (00078067066)

Pricing Information	N/A
NDC Package Code	0078-0670-66
Billing NDC	00078067066
Package	120 TABLET, FILM COATED in 1 BOTTLE (0078-0670-66)
Marketing Start Date	2016-07-12
NDC Exclude Flag	N